Variant report
Variant | nsv1005635 |
---|---|
Chromosome Location | chr3:162112453-162144236 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs115963866 | chr3:162118429-162118430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs6441452 | chr3:162118430-162118431 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs552457363 | chr3:162118434-162118435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs559400804 | chr3:162118468-162118469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs528063466 | chr3:162118469-162118470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568897535 | chr3:162118476-162118477 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200443193 | chr3:162118497-162118498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs68090745 | chr3:162118498-162118499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6441454 | chr3:162118499-162118500 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs536742361 | chr3:162118555-162118556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs6775708 | chr3:162118603-162118604 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs541565824 | chr3:162118624-162118625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9874193 | chr3:162118658-162118659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190279916 | chr3:162118663-162118664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs553596778 | chr3:162118669-162118670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573436908 | chr3:162118681-162118682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs536179709 | chr3:162118731-162118732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538752870 | chr3:162118772-162118773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182458943 | chr3:162118781-162118782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568797602 | chr3:162118836-162118837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs575754300 | chr3:162118881-162118882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544669200 | chr3:162118893-162118894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558290905 | chr3:162118926-162118927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577075446 | chr3:162118996-162118997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs546040146 | chr3:162118997-162118998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147675538 | chr3:162119007-162119008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2405754 | chr3:162119020-162119021 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs542149997 | chr3:162119097-162119098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs561525328 | chr3:162119119-162119120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs140972909 | chr3:162119129-162119130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530429649 | chr3:162119135-162119136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2405753 | chr3:162119167-162119168 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs62292337 | chr3:162119179-162119180 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs542623414 | chr3:162119186-162119187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs561003393 | chr3:162119217-162119218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs200589439 | chr3:162119234-162119235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs184296390 | chr3:162119284-162119285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79280795 | chr3:162119364-162119365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368634164 | chr3:162119379-162119380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567092655 | chr3:162119380-162119381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371928356 | chr3:162119381-162119382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs34353460 | chr3:162119382-162119383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs397700081 | chr3:162119385-162119386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77016574 | chr3:162119386-162119387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535769976 | chr3:162119441-162119442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs142432470 | chr3:162119467-162119468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532410537 | chr3:162119480-162119481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550569974 | chr3:162119563-162119564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs574991298 | chr3:162129400-162129401 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs548756776 | chr3:162129409-162129410 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 21909424 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162118400-162119600 | Enhancers | Fetal Heart | heart |
2 | chr3:162129400-162129800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
3 | chr3:162129400-162130000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
4 | chr3:162129400-162130000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
5 | chr3:162129600-162130000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
6 | chr3:162137000-162147000 | Weak transcription | H9 Cell Line | embryonic stem cell |